Pure Global

Anti-HBe (MAGLUMI® Anti-HBe ) - India CDSCO Medical Device Registration

Anti-HBe (MAGLUMI® Anti-HBe ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000036_c2d3f1f013c4468c98100037868ae867_72a369760b3f3b900a0a005ed97367f9. This device is marketed under the brand name CLIA. The license holder is SNIBE DIAGNOSTIC (India) Private Limited., and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
Anti-HBe (MAGLUMI® Anti-HBe )
UID: IMP/IVD/2023/000036_c2d3f1f013c4468c98100037868ae867_72a369760b3f3b900a0a005ed97367f9

Brand Name

CLIA

Device Class

Class C

Approving Authority

CDSCO

Product Information

The kit is an in vitro chemiluminescence immunoassay for the qualitative determination of Anti-HBe in human serum and plasma using the MAGLUMI series Fully-auto chemiluminescence immunoassay analyzer and Biolumi series Integrated System, and the assay is used as an aid in the diagnosis of HBV infection

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing